Humaneva provides clinical research data and insights to the medical community, enabling evidence-based decision-making and advancements in healthcare. They focus on delivering reliable data to support medical research and development.
Funding
$50M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Clinical research often suffers from fragmented data streams between patients, investigators, research centers, and varying data standards, hindering the efficient development of new treatments. Integrating diverse clinical research operations, including site networks, contract research organizations (CROs), and technology platforms, presents a significant challenge.
Solution
Humaneva Group integrates clinical research with technological innovation and data-driven approaches, creating a seamless data stream across the clinical research lifecycle. The group comprises a research site network (Pratia), a contract research organization (Kapadi), and a technology platform (Hyggio), which operate as an integrated alliance. This structure facilitates patient access, data reliability, and efficient project management, accelerating clinical trials and drug development. Humaneva's approach prioritizes patient care, leverages advanced technology, and upholds data excellence across various therapeutic areas, with a focus on oncology.
Target Audience
Humaneva's primary customers include biotech companies, pharmaceutical companies, hospitals, and research institutions involved in clinical trials and drug development, particularly in oncology.
Features
- Integrated SMO (Pratia) for patient recruitment and comprehensive care across a network of research sites.
- Specialized oncology CRO (Kapadi) providing full-service support for early-stage drug development.
- Technology platform (Hyggio) merging eSource, CTMS, and eTMF systems for in-depth trial insights.
- Harmonized operations between CRO and SMO levels through in-house technology.
- Scalable and cost-effective data analysis.
- Management of clinical projects within the CRO for vertical integration synergies.